Dendritic Cell-Dependent Inhibition of B Cell Proliferation Requires CD22

  • Santos L
  • Draves K
  • Boton M
  • et al.
43Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Recent studies have shown that dendritic cells (DCs) regulate B cell functions. In this study, we report that bone marrow (BM)-derived immature DCs, but not mature DCs, can inhibit BCR-induced proliferation of B cells in a contact-dependent manner. This inhibition is overcome by treatment with BAFF and is dependent on the BCR coreceptor CD22; however, it is not dependent on expression of the CD22 glycan ligand(s) produced by ST6Gal-I sialyltransferase. We found that a second CD22 ligand (CD22L) is expressed on CD11c+ splenic and BM-derived DCs, which does not contain ST6Gal-I-generated sialic acids and which, unlike the B cell-associated CD22L, is resistant to neuraminidase treatment and sodium metaperiodate oxidation. Examination of splenic and BM B cell subsets in CD22 and ST6Gal-I knockout mice revealed that ST6Gal-I-generated B cell CD22L plays a role in splenic B cell development, whereas the maintenance of long-lived mature BM B cells depends only on CD22 and not on α2,6-sialic acids produced by ST6Gal-I. We propose that the two distinct CD22L have different functions. The α2,6-sialic acid-containing glycoprotein is important for splenic B cell subset development, whereas the DC-associated ST6Gal-I-independent CD22L may be required for the maintenance of long-lived mature B cells in the BM.

Cite

CITATION STYLE

APA

Santos, L., Draves, K. E., Boton, M., Grewal, P. K., Marth, J. D., & Clark, E. A. (2008). Dendritic Cell-Dependent Inhibition of B Cell Proliferation Requires CD22. The Journal of Immunology, 180(7), 4561–4569. https://doi.org/10.4049/jimmunol.180.7.4561

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free